Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 027 541.2 |
96 | EP file number | EAKZ | 06 75 4405.6 |
86 | WO file number | WAKZ | PCT/EP2006/005800 |
97 | EP publication number | EPN | 1902141 |
87 | WO publication number | WPN | 2006133955 |
54 | Designation/title | TI | ADAMTS13-HALTIGE ZUSAMMENSETZUNGEN MIT THROMBOLYTISCHER WIRKUNG |
51 | IPC main class | ICM (ICMV) | C12Q 1/37 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 7/02 (2006.01), A61P 9/10 (2006.01), A61K 38/43 (2006.01) |
22 | DE application date | DAT | Jun 16, 2006 |
96 | EP application date | EAT | Jun 16, 2006 |
86 | WO application date | WAT | Jun 16, 2006 |
43 | Date of first publication | OT | Dec 21, 2006 |
| Date of publication of grant | PET | Feb 8, 2012 |
71/73 | Applicant/owner | INH | CBR Institute for Biomedical Research, Boston, Mass, US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
72 | Inventor | IN | SCHEIFLINGER, Friedrich, A-1090 Vienna, AT; PLAIMAUER, Barbara, A-1060 Vienna, AT; WAGNER, Denisa, Dover, MA 02030, US; CHAUHAN, Anil, Kumar, Brookline, MA 02445, US |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 729323 P Oct 21, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 771265 P Feb 7, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 691927 P Jun 17, 2005
|
| Due date | FT FG | Jun 30, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001902141 Searchable text:
EP000001902141 Original document:
EP000001902141B1 Searchable text:
EP000001902141B1 Original document:
WO002006133955 Searchable text:
WO002006133955 |
43 | Date of first publication | EVT | Dec 21, 2006 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 12, 2024 (Show all update days)(Hide all update days)- Nov 12, 2024
- Representative: changed
- Procedures: New representative details, New representative details, 14.09.2017: changed
- May 28, 2024; Jun 3, 2023; May 26, 2022; Nov 25, 2021; Oct 19, 2021; Jul 28, 2021; Jun 1, 2021; Nov 30, 2020; May 27, 2020; Aug 17, 2019; May 29, 2019; Oct 29, 2018; Jun 7, 2018; Oct 26, 2017; Sep 15, 2017; Aug 31, 2017; Jul 25, 2017; Jul 20, 2017; Jul 8, 2017; Nov 25, 2016; Jul 7, 2016; Aug 25, 2015; Jul 11, 2015; May 9, 2015; Jul 24, 2014; Jul 8, 2014; Sep 24, 2013; Jul 17, 2013; Jul 9, 2013; Mar 7, 2013; Feb 1, 2013; Nov 8, 2012; Sep 20, 2012; Sep 18, 2012; Aug 24, 2012; Jul 14, 2012; Jul 10, 2012; Apr 5, 2012; Mar 10, 2012; Feb 11, 2012; Feb 9, 2012; Jan 19, 2012; Nov 10, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 19, 2012 |
| Issue number | HN | 45 |
| Year | PJ | 2012 |
| Publication date | VT | Nov 8, 2012 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Baxter Healthcare SA, Glattpark, Opfikon, CH; Baxter International Inc., Deerfield, Ill., US; CBR Institute for Biomedical Research, Boston, Mass, US |
71/73 | Previous applicant/owner | INHF | Baxter Healthcare SA, Zürich, CH, Baxter International Inc., Deerfield, Ill., US, CBR Institute for Biomedical Research, Boston, Mass, US |
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 24, 2017 |
| Issue number | HN | 35 |
| Year | PJ | 2017 |
| Publication date | VT | Aug 31, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Inc., Bannockburn, Ill., US; CBR Institute for Biomedical Research, Boston, Mass, US |
71/73 | Previous applicant/owner | INHF | Baxter Healthcare SA, Glattpark, Opfikon, CH, Baxter International Inc., Deerfield, Ill., US, CBR Institute for Biomedical Research, Boston, Mass, US |
View procedures New applicant/owner details (No.: 13)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 14, 2017 |
| Issue number | HN | 43 |
| Year | PJ | 2017 |
| Publication date | VT | Oct 26, 2017 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Baxalta GmbH, Glattpark, Opfikon, CH; Baxalta Incorporated, Bannockburn, Ill., US; CBR Institute for Biomedical Research, Boston, Mass, US |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Inc., Bannockburn, Ill., US, CBR Institute for Biomedical Research, Boston, Mass, US |
View procedures New applicant/owner details (No.: 14)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 18, 2021 |
| Issue number | HN | 47 |
| Year | PJ | 2021 |
| Publication date | VT | Nov 25, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | CBR Institute for Biomedical Research, Boston, Mass, US; Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP |
71/73 | Previous applicant/owner | INHF | Baxalta GmbH, Glattpark, Opfikon, CH, Baxalta Incorporated, Bannockburn, Ill., US, CBR Institute for Biomedical Research, Boston, Mass, US |
| Date of update of the procedure | REGT | Nov 25, 2021 |